Anosmia
Information
- Disease name
- Anosmia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04853836 | Completed | Phase 4 | Olfactory Disfunction and Co-ultraPEALut | November 15, 2020 | August 31, 2022 |
| NCT04957563 | Completed | N/A | Clinical Utility of Olfactory Rehabilitation: Treatment for Pacients With Neurosensorial Anosmia | October 20, 2009 | October 20, 2014 |
| NCT05812209 | Completed | Stellate Ganglion Block to Treat Long COVID 19 Case Series | September 1, 2022 | December 31, 2022 | |
| NCT03990766 | Completed | Phase 2 | Smell Changes & Efficacy of Nasal Theophylline | May 15, 2019 | January 15, 2021 |
| NCT04361474 | Completed | Phase 3 | Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity | May 18, 2020 | June 25, 2021 |
| NCT04377815 | Completed | Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste | April 23, 2020 | June 24, 2020 | |
| NCT05461365 | Completed | Phase 3 | Intranasal Insulin for COVID-19-related Smell Loss | January 4, 2021 | December 20, 2021 |
| NCT04388618 | Completed | Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia | June 15, 2020 | December 31, 2021 | |
| NCT04390165 | Completed | Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study | June 6, 2020 | November 30, 2020 | |
| NCT05445921 | Completed | Phase 1/Phase 2 | Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction | September 1, 2022 | December 12, 2022 |
| NCT05246059 | Completed | N/A | Anosmia and Covid-19 | June 3, 2020 | August 8, 2021 |
| NCT05226546 | Completed | Phase 2/Phase 3 | Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19 | February 1, 2021 | August 1, 2021 |
| NCT04473157 | Completed | COVID-19 in Patients With Anosmia in Egypt | July 1, 2020 | December 30, 2020 | |
| NCT04484493 | Completed | Phase 3 | Corticosteroid Nasal Spray in COVID-19 Anosmia | August 8, 2020 | November 3, 2020 |
| NCT04495816 | Completed | Phase 2 | COVID-19 Anosmia Study | July 15, 2020 | December 31, 2021 |
| NCT05184192 | Completed | Phase 2 | Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction | January 10, 2022 | August 29, 2023 |
| NCT02481609 | Completed | Early Phase 1 | NAC Trial for Anosmia | July 2014 | December 1, 2017 |
| NCT04657809 | Completed | Phase 2 | Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia | October 1, 2020 | March 20, 2021 |
| NCT04710394 | Completed | N/A | Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell | January 11, 2021 | March 11, 2022 |
| NCT04715932 | Completed | Phase 2 | Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN) | February 18, 2021 | June 7, 2021 |
| NCT05152030 | Completed | The Clinical Applicability of the 'TIB' Olfactory Test Device | November 1, 2020 | September 16, 2021 | |
| NCT04789499 | Completed | Phase 2 | Smell in Covid-19 and Efficacy of Nasal Theophylline | March 15, 2021 | December 30, 2021 |
| NCT04797936 | Completed | Phase 4 | BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19 | May 1, 2020 | January 8, 2021 |
| NCT06423495 | Recruiting | N/A | Efficacy of Photobiomodulation in the Rehabilitation of Olfactory Dysfunctions Induced by Long COVID-19 | June 5, 2022 | December 22, 2024 |
| NCT04528329 | Recruiting | Phase 4 | Anosmia and / or Ageusia and Early Corticosteroid Use | March 30, 2021 | December 30, 2023 |
| NCT05040659 | Recruiting | Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2 | November 14, 2022 | May 1, 2025 | |
| NCT05061329 | Recruiting | The Nasal Microbiome and Its Importance in Disease | December 21, 2020 | December 31, 2026 | |
| NCT05364125 | Recruiting | N/A | Olfactory Training on Smell Dysfunction Patients in HK | July 1, 2022 | June 30, 2025 |
| NCT05562050 | Recruiting | Characteristics of the Anosmic Olfactory Mucosa | November 1, 2023 | October 30, 2024 | |
| NCT05912881 | Recruiting | N/A | Chemosensory Dysfunction and Recovery in Endoscopic Endonasal Skull Base Surgery | February 1, 2023 | January 1, 2026 |
| NCT06204432 | Recruiting | Phase 2 | Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction | December 1, 2023 | December 2024 |
| NCT04964414 | Terminated | Phase 1/Phase 2 | Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19 | September 30, 2021 | March 29, 2023 |
| NCT03680911 | Terminated | Phase 3 | NAC for Head Trauma-induced Anosmia | October 12, 2018 | January 7, 2020 |
| NCT05395845 | Unknown status | Early Phase 1 | Value of Platelet-Rich Plasma in Post Severe Acute Respiratory Syndrome Coronavirus 2 | June 1, 2022 | January 1, 2023 |
| NCT04524754 | Unknown status | Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19 | July 11, 2020 | November 30, 2020 | |
| NCT05384561 | Unknown status | N/A | Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19 | May 2022 | March 2023 |
| NCT04384042 | Unknown status | Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study | June 6, 2020 | March 31, 2021 | |
| NCT04951362 | Unknown status | Phase 2/Phase 3 | Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia | April 20, 2021 | May 15, 2022 |
| NCT04764981 | Unknown status | N/A | Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19) | May 2021 | May 1, 2024 |
| NCT04466982 | Unknown status | Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection | July 2, 2020 | January 2022 | |
| NCT04408391 | Withdrawn | Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia | May 20, 2020 | July 6, 2020 | |
| NCT02179554 | Withdrawn | Does Cardiopulmonary Bypass Change Olfaction? | October 2014 | December 2015 | |
| NCT05760079 | Withdrawn | N/A | Lactoferrin for COVID-19-Induced Taste or Smell Abnormality | June 2022 | September 2022 |
| NCT04422275 | Withdrawn | Phase 2 | Coronavirus Smell Therapy for Anosmia Recovery | June 1, 2021 | December 31, 2023 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000458
- ICD10 preferred id (Insert disease from ICD10)
- D0015078
- ICD10 class code (Insert disease from ICD10)
- R43.0